A better understanding of the complex biochemical interactions that regulate metabolic homeostasis in healthy individuals and the altered metabolic phenotype in patients with metabolic disorders will likely lead to the development of more efficacious treatments
Methods We obtained the data from PubMed, Scopus, Embase, and Web of Science for all eligible studies, including clinical trials (RCT) and cohorts comparing GLP-1 RAs to placebo or other hypoglycemic agents in patients with HFpEF published until December 31st, 2024
At Klinic, we prioritize branded, FDA-approved medications like Wegovy to guarantee quality, safety, and reliable results
Gastrointestinal side effects at this dose are generally well tolerated by individuals who progressed gradually through lower doses
Addressing societal misconceptions and focusing on personal health journeys is essential
Occasional moderate drinking is not a crisis